Table 5.
Overall Survival | Progression Free Survival | |||||
---|---|---|---|---|---|---|
HR | 95%Cl | p | HR | 95%Cl | p | |
Age ≥ 65 | 1.80 | 1.06–3.05 | 0.028 | 2.02 | 1.21–3.37 | 0.007 |
LDH | 1.03 | 0.63–1.68 | 0.890 | 1.21 | 0.76–1.93 | 0.420 |
ECOG > 1 | 2.04 | 1.22–3.42 | 0.006 | 1.65 | 0.99–2.76 | 0.053 |
Bone marrow involvement | 1.02 | 0.53–1.94 | 0.939 | 1.26 | 0.67–2.35 | 0.468 |
Extranodal Disease | 0.73 | 0.39–1.36 | 0.335 | 0.61 | 0.34–1.12 | 0.113 |
Stage (IIIA-IVB) | 2.75 | 1.51–4.99 | 0.001 | 2.42 | 1.36–4.31 | 0.002 |
IPI(low- high) | 1.38 | 0.61–3.08 | 0.432 | 1.32 | 0.60–2.89 | 0.478 |
CONUT score | 1.15 | 1.04–1.26 | 0.003 | 1.19 | 1.08–1.31 | 0.001 |
(AUC = 0.74) (95% confidence interval Cl, 67.3–80.4)